Clinical trial
Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance
NCT01681264 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- September 30, 2014
- Completion date
- December 31, 2023
- Enrollment
- 137 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.